Return to work is critical goal following HSCT. However, late effects may impede return to normal activity after HSCT. In the case of inability to work, patients may need a work disability pension to ensure a reasonable livelihood. This study evaluated inability to work and need for disability pension among long-term survivors and analyzed possible determinants of need for social support. This retrospective, single-center study included all HSCT patients surviving ⩾ 5 years seen at the outpatient clinic between January 2013 and August 2015. There were 203 patients, median age at HSCT 35 years, and 50 years at time of study; median time between HSCT and study control was 12 years; 178 had allo-HSCT, 187 had a malignant disease. At time of study, 156 (77%) were working full or part-time, 47 (23%) were not working. In total, 76 (37%) survivors were receiving a work disability pension compared to 3.17% of the Swiss working population. Patients with a disability pension were significantly older at HSCT, were more often living alone, had more active physical and mental late effects, and higher score of fatigue compared to patients without. These findings underline the importance of screening for employment and the social consequences of non-employment in long-term survivors after HSCT.
INTRODUCTION
Hematopoietic stem cell transplantation (HSCT) is a reasonable treatment option for a variety of malignant and non-malignant disorders. Over the past decades, outcome of patients treated with HSCT has improved substantially. 1 With an increasing number of transplants performed yearly and improved survival, the number of patients overcoming the acute phase of transplantation is steadily increasing. By 2020, up to a million long-term survivors are expected worldwide. 2 Therefore, long-term survivorship has become an issue for patients treated with HSCT. After transplantation, long-term survivors expected to be cured from their primary disease and to recover their initial health status that enables them to live a normal life with appropriate physical, mental and social functioning.
Despite improvements in outcome, mortality remains increased in long-term survivors, 3 mainly as a consequence of relapse of the primary disease and the occurrence of late malignant and non-malignant complications. Even more than 10 years after transplantation life expectancy is not fully restored. 4 Furthermore, significant morbidity interferes with normal activity of daily life. 5 Employment is an important indicator of functional recovery of patients surviving cancer and HSCT [6] [7] [8] but physical and mental late effects may prevent HSCT survivors from returning to work. Additionally, non-employment may have a significant financial impact on the household income, particularly when survivors were contributing as primary or secondary wage earners before transplantation. 9, 10 In some cases, patients may need a work disability pension to ensure their minimal subsistence for life. 11 Repeated additional out-of pocket costs, which are common after HSCT further increase the financial burden for survivors. Many European countries instituted a work disability pension system for adult residents who have a physical or mental condition that prevents them from working, which should ensure a person's minimal subsistence for life. Therefore, the need for a disability pension may be considered as a marker of an increased risk of financial toxicity in long-term survivors.
Today, knowledge on return to work and risk factors among cancer survivors is growing. 7, 8, 12, 13 Comparatively, this knowledge is still limited for HSCT survivors. 6, 14, 15 Some studies have described return to work mainly in the early stage after HSCT. To our knowledge, there are no systematic data on long-term working inability and the need of financial social assistance in patients alive 5 years or longer after HSCT. The aim of this study was to evaluate the prevalence of long-term inability to work and need for work disability pension and their possible determinants among long-term survivors after HSCT.
PATIENTS AND METHODS
This single-center cross-sectional study conducted by the Basel Stem Cell Transplant Team of the University Hospital of Basel, Switzerland included all patients surviving ⩾ 5 years after first HSCT who were seen for their yearly follow-up visit at the outpatient clinic between January 2013 and August 2015, and were of working age (between 18 and 65) at the time of the follow-up visit and Swiss residents. In 2015, the average age for leaving the work market in Switzerland was estimated to be 66 years for men and 64.8 for women. 16 Non-residents were excluded from the study because they were not eligible for a Swiss work disability pension. The primary goal was to assess the prevalence of inability to work and the need for a work disability pension among HSCT long-term survivors, to analyze risk factors, and to compare the need for work disability pension of long-term survivors with an age matched Swiss general population. Clinical surveillance of HSCT recipients was approved by the local institutional review board. Patients' characteristics, HSCT conditioning regimens, clinical outcome and the socio-demographic data were collected prospectively and stored in the local institution database.
In total, there were 500 long-term survivors; 145 of them did not fulfill the inclusion criteria, and 152 did not come to the yearly follow-up visit during the study period ( Figure 1) ; therefore, the study cohort included 203 patients. The characteristics of the 203 long-term survivors belonging to the study cohort are shown on Table 1 . We assessed the occupational status (working, not working), the reasons for inability to work, and the need for a work disability pension in all patients. Students and household workers were ranked as work equivalents. In Switzerland, any person aged between 18 and 65 years with a complete or partial inability to work because of health related physical or psychological damage, is entitled to receive a work disability pension. During the follow-up visits, patients unable to work full-time were advised to apply for a pension. During the yearly follow-up visit, all active late effects were assessed for each long-term survivor using a center-specific quality-of-life questionnaire, which was completed by the patients prior to the visit. The severity of the symptoms was graded during the patients' visit. 17 Common terminology criteria for adverse events (CTCAE; Version 4.0) were used to classify and grade late effects, grade 1 being mild, asymptomatic or symptomatic not needing any intervention, and grade 3 and 4, severe and life-threatening, respectively. 18 For grading fatigue, Version 3.0 of the CTCAE was used as follows: grade 1, mild fatigue over baseline; grade 2, moderate or causing difficulty performing some activity of daily living (ADL); grade 3, severe fatigue interfering with ADL; grade 4, disabling. 19 To assess the burden of morbidity, the number of active late effects was counted for each patient. For the mental score, we assessed depression, anxiety, sleep disorders, suicidal ideation and cognitive problems. Social isolation was defined as patients living alone (not married, no partner, no children). Occupational status was defined as working full-time, working part-time either by personal choice or due to poor health condition, and not working either due to poor health condition or willing to work but unemployed. Work equivalents (study or household work) could not be classified into full-time or part-time work.
Risk factors for not working and for need of a disability pension were analyzed. We compared long-term survivors working versus not working, as well as those with and without a disability pension. Factors considered were patient-related (age, sex), disease-related (diagnosis, disease status at HSCT), transplant-related (type of transplantation, conditioning regimen, donor type, source of stem cells, chronic GVHD), and long-term outcome variables (late effects, Karnofsky score, fatigue score, morbidity, mental score, living alone or not, having children, and healthy life style factors post-transplant).
Multivariate analysis for risk factors was performed to calculate hazard ratio (HR) and 95% confidence intervals (CI) using a logistic regression analysis to compare the 2 groups. Cutoffs for binary variables were set as follows: ⩾ 30 years for age at HSCT (close to median age at HSCT), ⩾ 3 according to CTCEA for severity score (grade 3 is defined as severe and medically significant), and ⩾ 4 active late effects for burden of morbidity corresponding to the median number of active late effects. 20 The data tables from Swiss statistics from 2014, 21 which is the statistical office of Switzerland providing information on a national level were used to generate age-specific incidence rates for work disability pension. Incidence rates were used to calculate expected number of cases for our cohort. The standardized incidence ratios (SIR) were calculated by obtaining the ratio of observed to expected number of cases. The 95% confidence was estimated using a method described by Haenszel. To calculate SIR and AER according to the age, we used the eight age groups from the data tables (Swiss statistics), needed for the expected rates. All P-values are two-sided with type I error rate fixed at 0.05. Statistical analyses were performed with IBM SPSS Statistics, Version 23 (IBM Corp, Armonk, NY, USA).
RESULTS
Before transplantation, 200 (98%) of the 203 patients had part-time or full-time employment, while 3 were not working, one of whom was receiving a work disability pension for health reasons. Five years or longer after HSCT, 156 of 203 (77%) patients had a job or work equivalent, and 47 (23%) were not working. Among the 156 working patients, 78 (38%) were working full-time, 66 (33%) were working part-time (22 by personal choice; 44 due to poor health condition), and 12 (6%) were either studying or household workers ( Figure 1 ). Poor health condition was the main reason for not returning to work: 43 of the 47 long-term survivors were not working due to poor health condition, while 4 (2%) patients were willing to work but unemployed.
Of the 203 long-term survivors, 76 (37%) were granted a partial or full work disability pension. Among the 76 survivors needing a disability pension, none had a full-time job, one was working part-time by personal choice, two were studying, 29 had a part-time job due to poor health condition, and 44 were not working at all. Among the 127 patients without a work disability pension, 78 had a full-time job, 21 had a part-time job by 500 long-term patients (≥5 years post-HSCT) 145 patients not-fulfilling inclusion criteria Retired from work, n =100 <18 years at time of study, n =12 Non-residents, n =29 Figure 1 . The flowchart represents all long-term patients surviving 5 years or longer after HSCT, detailing included and excluded patients, and for included patients, detailing patients working and not working ⩾ 5 years after HSCT.
personal choice, 10 were household workers or studying, 15 had a part-time job due to poor health condition, and 3 were not working (Figure 2b ). The repartition of type of employment between patients with and without a disability pension was statistically highly significant (P o 0.001).
Risk factor analysis for employment and need for work disability pension Patients ⩾ 5 years after HSCT not working were compared to those who were working (Table 1) . In univariate analysis, not working was associated with older median age at HSCT and at the time of this Inability to work and need for disability pension post HSCT A Tichelli et al study, shorter interval between HSCT and this study, Karnofsky score ⩽ 70%, ⩾ 4 active late effects, morbidity score of at least one late effect of ⩾ 3, fatigue score of ⩾ 3, and mental problems. Likewise, patients with a work disability pension were compared to patients without (Table 1) . Patients with a disability pension were significantly older at the time of HSCT and at the time of this study, had a shorter interval between HSCT and this study, were more often living alone, more often had a Karnofsky score ⩽ 70%, more often had chronic GvHD of any degree, were more often physically inactive, had a higher number of physical and mental active late effects and a higher score of fatigue when compared to patients without a disability pension. Gender, primary disease, type of HSCT, conditioning regimen (MAC versus RIC), use of TBI for conditioning, source of stem cells, having children or not and smoking habits did not differ between the two groups. Considering the individual late effects, musculoskeletal, pulmonary and neurological complications, as well as anxiety, depression and sleep disorders were more often associated with the need for a disability pension (Table 2) .
In multivariate analysis, factors associated with not working were severity score ⩾ 3 for at least one late effect (RR, 3.133; 95% CI, 1.356-7.239; P = 0.008), increased mental score (RR, 3.730; 95% CI, 1.48-9.399; P = 0.005), ⩾ 4 active late effects (RR, 3.283; 95% CI, 1.401-7.692; P = 0.006), and fatigue score ⩾ 3 (RR, 3.025; 95% CI, 1.310-6.987; P = 0.01). Other patient-related and transplantassociated factors were not significant for non-employment. Factors associated with need for a work disability pension in multivariate analysis were low Karnofsky score, age ⩾ 30 year at HSCT and living alone. When excluding the variable Karnofsky score from the model, an increased relative risk was found for survivors ⩾ 30 years at time of HSCT (RR, 3.98; 95% CI, 1.55-10.21; P = 0.004), living alone (RR, 3.46; 95% CI, 1.37-8.74; P = 0.008), a fatigue score ⩾ 3 (RR, 9.95; 95% CI 3.98-24.87; P = o 0.0001), an increased mental score (RR, 3.99; 95% CI, 1.49-8.75; P = 0.006), and ⩾ 4 active late effects (RR, 3.61; 95% CI, 1.49-8.75; P = 0.004).
Standardized incidence ratio for work disability pension The observed incidence rate of needing a work disability pension after HSCT was 37.4 per 100 patients (Table 3 ). It was lower in patients below the age of 44 years at the time of this study (ranging between 18.2 and 23.2 per 100 persons-years), and higher in patients aged ⩾ 45 years (ranging between 35.7 and 55.2%). The expected incidence rate of a general Swiss working population is 3.17 per hundred person-years. The incidence rate increases progressively from 1.2 below the age of 30 years up to 9.13 for persons aged 60-65 years. Thus, the standardized incidence ratio (SIR) for work disability pension after HSCT was 11.81 (95% CI, 9.30-14.78). SIR was highest in younger patients (18.82; 2.24-66.89 when o30 years) and decreased progressively with increasing age, down to 5.54 (95% CI, 3.29-9.03). Compared with a general population the absolute excess risk (AER) for need of disability pension was 34 cases per 100 person-years (Table 3) . It was 21 for patients o 30 years and 42.4 for HSCT survivors aged 60-65 years at study time.
DISCUSSION
In the present study, we show that 77% of the patients surviving 5 years or longer after HSCT had returned to work, while 23% were not working. However, among those who had returned to work, 44 patients, that is, 22% of the whole cohort were working parttime due to poor health condition. Long-term survivors also had a significantly higher probability of needing work disability pension when compared to an age matched general population. Indeed, 37% of all long-term survivors and only 3.17% of a Swiss working population needed social financial support to manage day-to-day life. Older age at HSCT, living alone, poor physical or mental health condition and fatigue were possible determinants predicting the need for social support in survivors with a long median follow-up time of 12 years after HSCT. Our results on return to work after HSCT are consistent with the published data. Delayed return to work after autologous or allogeneic HSCT is mainly predicted by physical and mental dysfunction after HSCT. 6, 14, 22 In a Swedish study of 177 adult patients treated with allogeneic HSCT, 82% had a full-time occupational status before transplantation compared to 52% at last follow-up. Furthermore, 27% were working part-time, 4% were studying, and 20% were not working. 23 Predictors of not working or working part-time were sick leave, disability pension or early retirement. In another study, including 690 patients employed before HSCT, the majority of which were autologous HSCT (80%), 62.3% had returned to work at 1 year after HSCT, but 39% reported some change in their occupational status. In a small group of 51 young adults transplanted during childhood, 11 most were in a good health condition, but 75% had a lower income compared to the comparator Swedish population, with 43% at a level defined as poverty risk zone by the EU. 24 Compared to these publications, the relatively low rate of employment in our long-term patients suggests that the probability of return to work is determined mainly during the early phase following HSCT and does not continue to improve with time.
Return to work is a good indicator of physical and mental recovery after HSCT, while the need for a work disability pension could also be a marker for financial burden. Indeed, disability pension should ensure a person's minimal subsistence for life, 11 and is therefore the last financial safety net in the social security system. 25 Survivors who were primary or secondary wage earners before transplantation may have a significant decrease in the household income if this income is restricted to social security. 10 In such a situation, additional out-of pocket expenses due to uncovered costs of long-term follow-up surveillance and management can increase financial toxicity. In this sense, the need for a disability pension can represent a measure of the risk of financial toxicity after HSCT. We show here that long-term survivors have nearly a 12-fold increased risk of needing a disability pension, with a SIR of 11.81. Individual late effects such as musculoskeletal, pulmonary or neurological complications may play a role, but the burden of physical and mental morbidity rather than the individual late effect determines the need for a work disability pension. Older age is also a risk factor for disability pension. However, younger survivors showed a higher observed/expected ratio of disability pension (SIR 18.5 for patients o 30 years) but this finding can be explained by the lower expected rates in younger individuals. In absolute number, older patients, particularly those aged ⩾ 50 years were more likely to need a work disability pension. This explains the higher AER in the older age group survivors.
Limitations of our study include the fact that only patients seen at the outpatient clinic were evaluated. We cannot exclude an attrition bias due to the fact that seriously disabled patients or -more likely -patients with complete social integration Abbreviations: AER = absolute excess ratio: O/E = observed/expected ratio; SIR = standardized incidence ratio. The expected values were obtained from the data tables from Swiss Statistics.
a Age at time of evaluation of work disability pension of long-term survivors.
Inability to work and need for disability pension post HSCTwithout any health condition were less likely to present for followup. Another limitation is the fact that a work disability pension system is regulated on a national level, and we show here the data from a Swiss cohort. However, most European countries have a social security system, including a work disability pension and despite differences among the various national systems, there are common principles: Beneficiaries of disability support are individuals who are unable to work due to physical or mental issues. Furthermore, disability pension usually guarantees an equivalent to minimum wage or less. 10, 26 In this sense, we assume that our data is representative for long-term survivors in Europe.
Adverse consequences of financial toxicity after HSCT are an emerging but still underexplored issue. For HSCT survivors, no data on the outcome of survivors who are granted a disability pension are available. Our study was not designed to evaluate the impact of work disability pension on financial toxicity and potential consequences on the outcome of the long-term survivors. In a population-based cohort from Sweden, relative risk of mortality was higher for patients with disability pension than for individuals without. 27 The increased mortality among individuals granted a disability pension is not surprising and can be explained by the underlying disease for which a disability pension was granted. However, what is more surprising is that higher mortality was also reported for individuals granted a disability pension for 'benign', non-fatal diagnoses such as musculoskeletal diseases. 28, 29 While this issue remains controversial, 30, 31 we cannot exclude the possibility that individuals granted a disability pension are per se exposed to increased risk of poor health due to unfavorable lifestyle (smoking, alcohol, lack of exercise 29 ), social isolation, and loss of gratification of paid work among other possible causes. 28 The possible impact of need for a disability pension on physical and mental health and on the outcome of long-term survivors is still an unexplored field.
In conclusion, these findings underline the importance of screening for employment as well as social and financial consequences of non-employment in long-term survivors after HSCT. The burden of late effects, fatigue and mental problems are the major determinants predicting non-employment in long-term survivors after HSCT. Employment status is an important indicator of recovery after HSCT, but can also directly affect the financial situation of long-term survivors and their family. The increased rate of need for a disability pension suggests that a significant proportion of long-term survivors are at risk for financial toxicity. Knowledge on these issues offers the opportunity of early intervention on modifiable risk factors. Therefore, systematic inquiry on employment, need for a disability pension, and financial situation should become an integrated aspect of longterm survivorship care. Future studies need to evaluate the impact of need for disability pension on quality of life, physical and mental late effects and overall survival in long-term survivors.
